New York State Common Retirement Fund’s vTv Therapeutics VTVT Stock Holding History

New York State Common Retirement Fund’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3	Closed	–	–	3530
2021 Q2	$0	Sell	3 -800	-100%	-$81K	﹤0.01%	3573
2021 Q1	$91K	Sell	803 -232	-22%	-$22.8K	﹤0.01%	3101
2020 Q4	$77K	Hold	1,035	–	–	﹤0.01%	3118
2020 Q3	$73K	Hold	1,035	–	–	﹤0.01%	3055
2020 Q2	$93K	Buy	+1,035	New	+$102K	﹤0.01%	3011
2018 Q2	–	Sell	-108	Closed	-$18K	–	3220
2018 Q1	$18K	Hold	108	–	–	﹤0.01%	3067
2017 Q4	$26K	Hold	108	–	–	﹤0.01%	3067
2017 Q3	$26K	Hold	108	–	–	﹤0.01%	3079
2017 Q2	$21K	Hold	108	–	–	﹤0.01%	3166
2017 Q1	$28K	Hold	108	–	–	﹤0.01%	3101
2016 Q4	$21K	Hold	108	–	–	﹤0.01%	3103
2016 Q3	$31K	Hold	108	–	–	﹤0.01%	3105
2016 Q2	$25K	Hold	108	–	–	﹤0.01%	3133
2016 Q1	$22K	Hold	108	–	–	﹤0.01%	3114
2015 Q4	$29K	Buy	+108	New	+$30.3K	﹤0.01%	3145

Other funds holding VTVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WAG

Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

New York State Common Retirement Fund's VTVT Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of vTv Therapeutics (VTVT) in Q3 2021, closing a stake of 3 shares.

New York State Common Retirement Fund first reported a position in VTVT in Q4 2015 and held it in 15 quarters. The position peaked at $93K in Q2 2020. 31 funds tracked by Wall St. Rank hold VTVT as of Q3 2021.

New York State Common Retirement Fund reported no remaining vTv Therapeutics position as of Q3 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 3 vTv Therapeutics shares in Q3 2021.
New York State Common Retirement Fund first reported a position in vTv Therapeutics in Q4 2015 and held it in 15 quarters.
New York State Common Retirement Fund's vTv Therapeutics position peaked at $93K in Q2 2020.
31 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.